Balyasny Asset Management LLC Ocular Therapeutix, Inc Transaction History

Balyasny Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $76,244 - $165,685	36,656 Added 70.03%	89,000 $396,000
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $12,754 - $20,472	4,062 Added 8.41%	52,344 $164,000
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $147,972 - $245,763	32,168 Added 199.63%	48,282 $249,000
Q1 2023 May 15, 2023	SELL	$2.79 - $6.27 $24,766 - $55,658	-8,877 Reduced 35.52%	16,114 $84,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $65,226 - $110,210	24,991 New	24,991 $70,000

Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $55,561 - $96,355	18,459 New	18,459 $74,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $52,704 - $80,203	-10,912 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $67,217 - $131,707	10,912 New	10,912 $76,000
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $224,334 - $320,048	-16,704 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $264,257 - $369,325	16,704 New	16,704 $274,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.